Gene · 2921
Papers3,842
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
521 to 540 of 3,842
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| BSHXF-medicated serum combined with ADSCs regulates the TGF-β1/Smad pathway to repair oxidatively damaged NPCs and its component analysis. | J Ethnopharmacol | 2023 | 37277086 | PubTator, text mining | PubMed |
| Deciphering the single-cell transcriptome network in keloids with intra-lesional injection of triamcinolone acetonide combined with 5-fluorouracil. | Front Immunol | 2023 | 37275903 | PubTator, text mining | PubMed |
| CD200R signaling contributes to unfavorable tumor microenvironment through regulating production of chemokines by tumor-associated myeloid cells. | iScience | 2023 | 37275530 | PubTator, text mining | PubMed |
| Immuno-oncology-microbiome axis of gastrointestinal malignancy. | World J Gastrointest Oncol | 2023 | 37275452 | PubTator, text mining | PubMed |
| CXCR2 expression during melanoma tumorigenesis controls transcriptional programs that facilitate tumor growth. | Mol Cancer | 2023 | 37270599 | PubTator, text mining | PubMed |
| Cytokine signaling converging on IL11 in ILD fibroblasts provokes aberrant epithelial differentiation signatures. | Front Immunol | 2023 | 37266432 | PubTator, text mining | PubMed |
| Single-cell technologies in multiple myeloma: new insights into disease pathogenesis and translational implications. | Biomark Res | 2023 | 37259170 | PubTator, text mining | PubMed |
| Multi-omics blood atlas reveals unique features of immune and platelet responses to SARS-CoV-2 Omicron breakthrough infection. | Immunity | 2023 | 37257450 | PubTator, text mining | PubMed |
| Pathological pathway analysis in an experimental rheumatoid arthritis model and the tissue repair effect of acupuncture at ST36. | Front Immunol | 2023 | 37256145 | PubTator, text mining | PubMed |
| Accelerated replicative senescence of ataxia-telangiectasia skin fibroblasts is retained at physiologic oxygen levels, with unique and common transcriptional patterns. | Aging Cell | 2023 | 37254625 | PubTator, text mining | PubMed |
| Spatial analysis of stromal signatures identifies invasive front carcinoma-associated fibroblasts as suppressors of anti-tumor immune response in esophageal cancer. | J Exp Clin Cancer Res | 2023 | 37254126 | PubTator, text mining | PubMed |
| Exploration and Validation of Pancreatic Cancer Hub Genes Based on Weighted Gene Co-Expression Network Analysis and Immune Infiltration Score Analysis. | Pharmgenomics Pers Med | 2023 | 37252337 | PubTator, text mining | PubMed |
| Exploring the link between cardiovascular risk factors and manifestations in latent tuberculosis infection: a comprehensive literature review. | Egypt Heart J | 2023 | 37249745 | PubTator, text mining | PubMed |
| Metformin Resistance Is Associated with Expression of Inflammatory and Invasive Genes in A549 Lung Cancer Cells. | Genes (Basel) | 2023 | 37239373 | PubTator, text mining | PubMed |
| Bioinformatics and network biology approach to identifying type 2 diabetes genes and pathways that influence the progression of breast cancer. | Heliyon | 2023 | 37234659 | PubTator, text mining | PubMed |
| A novel molecular mechanism mediated by circCCDC134 regulates non-small cell lung cancer progression. | Thorac Cancer | 2023 | 37231545 | PubTator, text mining | PubMed |
| Neutrophil sub-types in maintaining immune homeostasis during steady state, infections and sterile inflammation. | Inflamm Res | 2023 | 37212866 | PubTator, text mining | PubMed |
| Upregulation of ITGB6 in primary palmar hyperhidrosis. | Adv Clin Exp Med | 2023 | 37212774 | PubTator, text mining | PubMed |
| Screening core genes and signaling pathways after SFTSV infection by integrated transcriptome profiling analysis. | Virus Res | 2023 | 37211158 | PubTator, text mining | PubMed |
| Analysis of immunogenic cell death in ascending thoracic aortic aneurysms based on single-cell sequencing data. | Front Immunol | 2023 | 37207221 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2921/papers?page=27